"Huge" Personalized Med Opportunity For Device/Dx Firms - PwC Survey
This article was originally published in The Gray Sheet
Executive Summary
Device and diagnostics companies stand to benefit from a global health care system that will increasingly lean toward personalized medicine, according to a PricewaterhouseCoopers survey